Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2025-12-16 @ 8:34 PM
Study NCT ID:
NCT06517433
Status:
None
Last Update Posted:
2024-07-24 00:00:00
First Post:
2024-07-18 00:00:00
Brief Title:
First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b
Sponsor:
Organization:
Mersana Therapeutics